BRZE
The setup
Braze is heading into its first-quarter earnings report on Wednesday with a little extra swagger. Shares were up Tuesday after BTIG analyst Nick Altmann said the company could post 22.7% organic revenue growth and potentially raise fiscal 2027 guidance a notch.
Why the Street is leaning in
Altmann kept a Buy rating on the stock and left his price target at $30, which is basically Wall Street’s way of saying, “We like the vibe, now prove it.” The bigger story, though, is that investors are staring past the headline numbers and watching the forward-looking stuff: cRPO growth, enterprise bookings, and whether BrazeAI Decisioning Studio is turning into an actual revenue engine instead of just a shiny demo.
The AI angle isn’t just marketing glitter
BTIG’s fieldwork suggests customers are already talking about:
- more net-new logo adoption,
- expansion plans tied to BrazeAI Decisioning Studio,
- early interest in BrazeAI Agent Console and BrazeAI Operator.
The analyst also heard that Braze is showing up more often in competitive bake-offs, while some companies are actively replacing Salesforce and Adobe in their martech stacks. That doesn’t mean Braze has won the war, but it does mean the pitch deck is landing.
What investors should watch on Wednesday
The earnings report itself matters, sure. But the real tell will be whether management sounds confident enough to keep lifting the long-term story without sounding like they’re trying too hard at an investor day karaoke night.
If cRPO keeps humming and the AI products look more like a business than a buzzword, BRZE could keep its momentum. Big picture: in software land, growth is good — but growth with a believable AI story is what gets people to keep buying the stock.